X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
e4599 (5) 5
bevacizumab (4) 4
non-small-cell lung cancer (4) 4
angiogenesis (2) 2
antibodies, monoclonal, humanized (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
avail (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
chemotherapy (2) 2
combination (2) 2
humans (2) 2
index medicus (2) 2
lung neoplasms - drug therapy (2) 2
lung neoplasms - mortality (2) 2
oncology (2) 2
vascular endothelial growth factor a - antagonists & inhibitors (2) 2
age factors (1) 1
aged (1) 1
aged, 80 and over (1) 1
angiogenesehemmer (1) 1
angiogenesis inhibitor (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
angiogenesis inhibitors - adverse effects (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
antiangiogenesis (1) 1
antiangiogenic agents (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
cancer (1) 1
carboplatin (1) 1
carboplatin/paclitaxel (1) 1
carcinoma, non-small-cell lung - blood supply (1) 1
carcinoma, non-small-cell lung - secondary (1) 1
cisplatin - administration & dosage (1) 1
combination therapy (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
disease progression (1) 1
drug therapy (1) 1
endothelial growth-factor (1) 1
erlotinib (1) 1
factor expression (1) 1
factor monoclonal-antibody (1) 1
female (1) 1
follow-up studies (1) 1
general practice / family medicine (1) 1
geriatrics/gerontology (1) 1
infectious diseases (1) 1
internal medicine (1) 1
lung cancer (1) 1
lung cancer, non-small cell (1) 1
lung neoplasms - blood supply (1) 1
male (1) 1
medicine & public health (1) 1
medicine/public health, general (1) 1
methods (1) 1
middle aged (1) 1
nicht-kleinzelliges bronchuskarzinom (1) 1
nsclc (1) 1
paclitaxel (1) 1
pharmacology/toxicology (1) 1
phase-ii (1) 1
phase-iii trial (1) 1
platin-based chemotherapy (1) 1
platin-haltige chemotherapie (1) 1
plus carboplatin (1) 1
recurrent (1) 1
respiratory system (1) 1
sex factors (1) 1
survival analysis (1) 1
survival rate (1) 1
treatment outcome (1) 1
trial (1) 1
tumor-growth (1) 1
vascular endothelial growth factor a - adverse effects (1) 1
vascular endothelial growth factor a - metabolism (1) 1
vegf (1) 1
vegf antagonist (1) 1
vegf antibody (1) 1
vegf-antagonist (1) 1
べバシズマブ (1) 1
カルボプラチン/パクリタキセル (1) 1
肺癌 (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Japanese Journal of Lung Cancer, ISSN 0386-9628, 06/2006, Volume 46, Issue 3, pp. 277 - 281
Journal Article
Wiener Medizinische Wochenschrift, ISSN 0043-5341, 11/2007, Volume 157, Issue 21, pp. 576 - 578
Journal Article
肺癌, ISSN 0386-9628, 2006, Volume 46, Issue 3, pp. 277 - 281
肺癌による死亡は全癌死の約3分の1を占め,乳癌,前立腺癌及び結腸癌による死亡を総合した数よりも多い.肺癌を発症した患者の約85%はその疾患により死亡する.ヒト化抗VEGF MAb(モノクローナル抗体)であるベバシズマブ(bevacizumab; AvastinTM)のこの肺癌における臨床成績を紹介する.... 
肺癌 | E4599 | べバシズマブ | Non-small-cell lung cancer(NSCLC) | カルボプラチン/パクリタキセル
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.